Catalent Expands with Two New Deals in China


Mar 11, 2013

Catalent Pharma Solutions said today it was undertaking a major expansion of activity in China by acquiring a Chinese-based maker of nutritional softgel products, and joining with a second on a separate joint venture focused on clinical trial supplies. Catalent said it will acquire a majority stake in Haining-based, privately-held Zhejiang Jiang Yuan Tang Biotechnology for an undisclosed price. “Catalent intends to work with regulators for future expansion into OTC and prescription softgel manufacturing in China,” the company said in a statement. Read the full story here.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments